Question 1

What is the catalog number for Altretamine, GPX4 inhibitor; Ferroptosis inducer?

Accepted Answer

The catalog number for Altretamine, GPX4 inhibitor; Ferroptosis inducer is TBI5592-20MG.

Question 2

What sizes are available for Altretamine, GPX4 inhibitor; Ferroptosis inducer?

Accepted Answer

Altretamine, GPX4 inhibitor; Ferroptosis inducer is available in the following size(s): 20 mg.

Question 3

Is Altretamine, GPX4 inhibitor; Ferroptosis inducer in stock?

Accepted Answer

Altretamine, GPX4 inhibitor; Ferroptosis inducer is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 5

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Altretamine, GPX4 inhibitor; Ferroptosis inducer

Product Specifications

Shipping Conditions

Frequently Asked Questions

Explore Other Products

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

MiTF (Microphthalmia Transcription Factor) (MITF/915), CF488A conjugate, 0.1mg/mL

Cytokeratin 8 (KRT8) (KRT8/2115), CF488A conjugate, 0.1mg/mL

Fibronectin (HFN7.1), 0.2mg/mL

Neurofilament (NF-L) (Neuronal Marker) (NEFL/2983R), CF640R conjugate, 0.1mg/mL

Thyroid Stimulating Hormone, beta (TSH beta) (Pituitary Marker) (TSHb/1317), 0.2mg/mL